Press Releases

July 22, 2008
Life Science Angels Makes Additional Investment in NeuroHealing Pharmaceuticals

July 16, 2008
NeuroHealing Pharmaceuticals Receives Grant from the FDA Office of Orphan Drugs for Clinical Development of NH001 to Treat Patients in a Vegetative and Minimally Conscious State

February 19, 2008
NeuroHealing Pharmaceuticals Initiates Phase II Clinical Trial of NH004 for Sialorrhea Control in Parkinson’s Disease Patients

January 3, 2008
NeuroHealing Pharmaceuticals Appoints Burt Adelman, M.D., To Board Of Directors

December 13, 2007
The Michael J. Fox Foundation Awards Funding To NeuroHealing Pharmaceuticals Researchers for a Phase II Clinical Trial of NH004 for Sialorrhea Control in Parkinson's Disease Patients

March 12, 2007
NeuroHealing Pharmaceuticals Presents Clinical Data for NH001 in Coma Recovery at the American Society for Experimental NeuroTherapeutics (ASENT) Annual Meeting

September 12, 2006
NeuroHealing Pharmaceuticals CEO, Neal Farber, to Speak at the Dow Jones VentureWire Health Care Innovations 2006 Conference, the Biotech & Life Sciences Global Venture Congress 2006, and the Life Sciences Venture Summit 2006

May 25, 2006
NeuroHealing Receives Orphan Drug Designation for NH001 for Patients in Vegetative State or Minimally Conscious State

April 5, 2006
Life Science Angels Invests in NeuroHealing Pharmaceuticals

February 10, 2006
NeuroHealing to Present at 4th World NeuroRehabilitation Congress, Hong Kong, Feb 12-16 2006

January 17, 2006
NeuroHealing Announces IND Clearance for NH001 for Coma Patients

November 3, 2005
NeuroHealing to Present at Rodman & Renshaw Techvest Conference

August 31, 2005
NeuroHealing Announces IND Submission for NH001 for Coma Patients

December 8, 2004
NeuroHealing Commences Clinical Trial of NH001 for Coma Patients

June 14, 2004
Harvard Biotechnology Club Awards NeuroHealing Pharmaceuticals
First Prize in Business Plan Competition


In the News
September 8, 2006, New York Times
Mental Activity Seen in a Brain Gravely Injured

May 1, 2005, Start-Up Magazine
Jumpstarting the brain's healing - NeuroHealing profiled in Start-Up Magazine

March 8, 2005, Business Wire
NeuroHealing selected to present at "Best in Show Competition" in EC21 BioVentures Conference in London - March 22, 2005

December 20, 2004, Mass High Tech
Company Targets Coma Patients with Compound

October 4, 2004, Forbes Magazine
Twilight Zone

June 7, 2004, IN VIVO
Selected Start-Ups

June 28, 2004, Mass High Tech
NeuroHealing Pharmaceuticals Focuses on Coma Recovery Treatment

May 2004 - GSAS Harvard Biotechnology Club
Neurohealing Pharmaceuticals - FIRST PLACE